Specialist in nuclear medicine, court-certified expert witness, and Managing Director of Theranosticum Vienna.
Dr. Werner Langsteger is a specialist in nuclear medicine and internal medicine with many years of clinical and scientific experience in molecular imaging and theranostic approaches in prostate cancer.
Following his medical studies, he specialized early in nuclear medicine and worked for many years at leading nuclear medicine institutions in Austria. A particular focus of his clinical work has been PET/CT diagnostics, the advancement of tracer-based imaging techniques, and the evaluation of oncological conditions.
In parallel with his clinical work, Dr. Langsteger has been actively involved in research and has contributed to numerous publications in international peer-reviewed journals, particularly in the fields of PSMA-based PET imaging, the detection of metastases, and the development of modern nuclear medicine procedures.
As co-founder and director of Theranosticum Vienna, Dr. Langsteger brings together his expertise in clinical practice, research, and interdisciplinary collaboration within a specialized center focused on precise diagnostics and individually tailored therapies, particularly for prostate cancer and neuroendocrine tumors.
Memberships
- World Association Radiopharmaceutical & Molecular Therapy (WARMTH, 2015)
- Chirurgische Arbeitsgemeinschaft Endokrinologie (CAEK, 2005))
- PET eV | Berufsverband Deutscher Nuklearmediziner (BDN, 2002)
- Radiological Society of North America (RSNA, 2001)
- Österreichische Chirurgengesellschaft (ÖCG, 2000)
- Academy of Molecular Imaging & Institute of Clinical PET (AMI & ICP, 1998)
- American Association of Clinical Endocrinology (AACE, 1995)
- Sektion Schilddrüse | Deutsche Gesellschaft für Endokrinologie (DGE, 1994)
- Österreichische Gesellschaft Innere Medizin (ÖGIM, 1994)
- The Society of Nuclear Medicine of North America (SNM, 1992)
- European Thyroid Association (ETA, 1992)
- European Association of Nuclear Medicine (EANM, 1988)
- Berufsverband Deutscher Nuklearmediziner (BDN, 1988)
- Deutsche Gesellschaft für Nuklearmedizin (DGN, 1988)
- Österreichische Gesellschaft für Nuklearmedizin (OGNT, 1986)
Languages
- German
- English
Professional Background
Key Positions (2018–2019)
- 1998 | Chairman & Head, Institute of Nuclear Medicine & Endocrinology
- 2003 | Chairman & Head, PET–CT Center Linz
- 2010 | Chairman & Head, Thyroid Center Linz
- 2011 | Chairman & Head, Nuclear Medicine Therapy Unit
Additional Positions
- 2012–2020 | President & First Vice President, VLKÖ
- 2012–2019 | Member of the Radiation Emergency Task Force | Government of Upper Austria
- 2011–2018 | President & Congress Chair, OGNT
- 2011–2018 | Committee Member (Oncology | Thyroid | Ethics), EANM
- 2010–2011 | Congress President, EANM (Vienna & Birmingham)
- 2000–2003 | Visiting Professor (Zurich | Essen | New York, MSKCC)
Publications
- Academy of Molecular Imaging (Orlando USA, 2006)
- Prostate Cancer (PIRAMAL Global, 2015 - 2018)
- Thyroid Cancer (EISAI Global, 2015 - 2018)
- Platinresistent Ovarian Cancer (MSD, 2013 - 2014)
- Etarfolatide in Ovarian Cancer (ENDOCYTE Global, 2013 - 2014)
- Thyroid Cancer (THYROGEN, 2012 - 2013)
- Oncology (St VINCENT’S GROUP, 2011 - 2018)
- Research Board (AMERICAN BIOGRAPHICAL INST, 2006 - 2007)
- Prostate & Thyroid Cancer (IASON Europe, 2005 - 2012)
“Modern nuclear medicine requires precise diagnostics and a clear medical foundation. It is important to me to understand each patient’s individual situation, explain findings in a clear and understandable way, and make medical decisions transparently.”
Dr. Werner Langsteger
We take time for what matters - your care
If you have questions or would like to schedule an appointment, we are here for you.
In a personal consultation, we discuss your concerns in a calm setting and outline the next steps together.
Our team will get back to you promptly and support you competently and reliably - from the first contact through to your therapy appointment.
